The CDTI awards Biohope one of the grants, funded by NextGenerationEU program, for companies distinguished with the European Seal of Excellence.

Published On: August 8th, 2022

Biohope has been awarded one of the grants from the Center for the Development of Industrial Technology (CDTI), aimed at Spanish companies that have obtained the Seal of Excellence in the first call of the European Innovation Council Accelerator of the Horizon Europe program.

This grant is part of the Recovery, Transformation and Resilience Plan, sponsored by the European Union (NextGenerationEU), and will provide invaluable support to carry out the company’s next milestones.

The project, “IMMUNOBIOGRAM-RT” (Expedient number: SoE-20211012), will be executed during 2022-2023 (with an extension granted towards 2024) and has a total budget of 3.325.204,00€. Please see the final resolution for more detail.

The main objective of the project is the indication of Immunobiogram-RT to validate the pre- and early phases of RT and expand business scalability by providing clinical immunology laboratories with easy-to-use kits and fluorometers to perform on-site testing.

The project is subsidized by the CDTI and supported by the Ministry of Science and Innovation. This project has been finances by CDTI through a grant from the program for SMEs with the Horizon Europe EIC Accelerator Seal of Excelence.